tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX

Avalo Therapeutics (AVTX) Financial Statements

863 Followers

Avalo Therapeutics Financial Overview

Avalo Therapeutics's market cap is currently ―. The company's EPS TTM is $-318.889; its P/E ratio is -0.04; Avalo Therapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 236.00K$ 643.00K$ 475.00K
Gross Profit$ 80.00K-$ -11.00K$ -65.00K$ -76.00K
EBIT$ -5.23M$ -8.18M$ -5.22M$ -8.19M$ -9.95M
EBITDA$ -5.20M$ -8.13M$ -4.05M$ -7.80M$ -9.56M
Net Income Common Stockholders$ -121.29M-$ -5.23M$ -8.19M$ -9.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 110.18M-$ 10.20M$ 6.32M$ 16.76M
Total Assets$ 119.96M-$ 29.27M$ 24.23M$ 36.23M
Total Debt$ 0.00$ 0.00$ 0.00$ 14.12M$ 19.77M
Net Debt$ -110.18M$ 0.00$ -10.20M$ 7.80M$ 3.00M
Total Liabilities$ 236.27M-$ 14.57M$ 31.20M$ 42.50M
Stockholders Equity$ -112.54M-$ 14.70M$ -6.97M$ -6.27M
Cash Flow-
Free Cash Flow$ -6.20M$ -2.80M$ -6.80M$ -10.98M$ 146.00K
Operating Cash Flow$ -6.20M-$ -6.80M$ -10.98M$ 146.00K
Investing Cash Flow$ 356.00K---$ -133.00K
Financing Cash Flow$ 108.61M-$ 10.70M$ 598.00K$ 13.75M
Currency in USD

Avalo Therapeutics Earnings and Revenue History

Avalo Therapeutics Debt to Assets

Avalo Therapeutics Cash Flow

Avalo Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis